中国现代医生
中國現代醫生
중국현대의생
CHINA MODERN DOCTOR
2014年
23期
37-39
,共3页
抗生素%金刚藤%盆腔炎性疾病
抗生素%金剛籐%盆腔炎性疾病
항생소%금강등%분강염성질병
Antibiotics%Jingangteng%Pelvic inflammatory disease
目的:探讨抗生素联合金刚藤治疗盆腔炎性疾病的临床疗效。方法将120例盆腔炎性疾病患者妇女随机分为两组。治疗组(60例)静滴抗生素联合口服金刚藤胶囊,对照组(60例)单纯静滴抗生素,10 d为1个疗程,共3个疗程。结果120例盆腔炎性疾病患者治疗3个疗程后,治疗组总有效率93.33%,明显优于对照组的83.33%,差异有统计学意义(P<0.05);治疗组症状体征改善优于对照组,差异有统计学意义(P<0.05)。结论抗生素联合金刚藤治疗盆腔炎性疾病,显著改善患者临床症状,疗效明显提高,可较好预防盆腔炎性疾病后遗症的发生。
目的:探討抗生素聯閤金剛籐治療盆腔炎性疾病的臨床療效。方法將120例盆腔炎性疾病患者婦女隨機分為兩組。治療組(60例)靜滴抗生素聯閤口服金剛籐膠囊,對照組(60例)單純靜滴抗生素,10 d為1箇療程,共3箇療程。結果120例盆腔炎性疾病患者治療3箇療程後,治療組總有效率93.33%,明顯優于對照組的83.33%,差異有統計學意義(P<0.05);治療組癥狀體徵改善優于對照組,差異有統計學意義(P<0.05)。結論抗生素聯閤金剛籐治療盆腔炎性疾病,顯著改善患者臨床癥狀,療效明顯提高,可較好預防盆腔炎性疾病後遺癥的髮生。
목적:탐토항생소연합금강등치료분강염성질병적림상료효。방법장120례분강염성질병환자부녀수궤분위량조。치료조(60례)정적항생소연합구복금강등효낭,대조조(60례)단순정적항생소,10 d위1개료정,공3개료정。결과120례분강염성질병환자치료3개료정후,치료조총유효솔93.33%,명현우우대조조적83.33%,차이유통계학의의(P<0.05);치료조증상체정개선우우대조조,차이유통계학의의(P<0.05)。결론항생소연합금강등치료분강염성질병,현저개선환자림상증상,료효명현제고,가교호예방분강염성질병후유증적발생。
Objective To study the effect of antibiotic combined with Jingangtengin treatment of pelvic inflammatory disease. Methods A total of 120 cases of pelvic inflammatory disease were randomly divided into two groups. The treatment group of 60 cases were treated with intravenous antibiotics combined with oral Jingangteng capsule, the con-trol group of 60 cases were treated with simple intravenous antibiotics, 10 days for a course of treatment, a total of 3 courses. Results The 120 cases of patients with pelvic inflammatory disease after 3 courses of treatment, the total effec-tive rate of treatment group was 93.33%, significantly better than the control group(83.33%), the difference was statis-tically significant(P<0.05); Signs and symptoms improved in treatment group was better than the control group, the dif-ference was statistically significant(P<0.05). Conclusion The antibiotic combined Jingangteng in treatment of pelvic in-flammatory disease, can improve clinical symptoms significantly, curative effect is obviously improved, and can better prevent sequelae of pelvic inflammatory disease.